2018•Journal of Clinical VirologyRequires access

Rare emergence of drug resistance in HIV-1 treatment-naïve patients receiving elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide for 144 weeks

Nicolas Margot, Stephanie M. Cox, Moupali Das, Scott H. McCallister, Michael D. Miller, Christian Callebaut

Open publisher page 23 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 23 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Elvitegravir, Cobicistat, Tenofovir alafenamide, Emtricitabine, Medicine, Internal medicine, Human immunodeficiency virus (HIV), Regimen

Back to paper search Browse research topics Original source

Rare emergence of drug resistance in HIV-1 treatment-naïve patients receiving elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide for 144 weeks — Research Paper | ScholarLens